Timing of HCG Administration in IUI Cycles

Timing of Human Chorionic Gonadotropin Administration in Intrauterine Insemination Cycles

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

Women will be randomly divided into 3 groups; the first group will undergo IUI at the time HCG administration, the second group will undergo IUI 12 hours after HCG administration and the third group will undergo IUI 34-36 hours after HCG administration.

Inclusion Criteria:

• Mild male factor infertility or unexplained infertility.

Exclusion Criteria:

• Advanced male factor infertility.
• Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria.
• Endometriosis.
• Tubal disease.
• Uterine abnormalities or myoma.
• Previous uterine surgery.
• Metabolic or hormonal abnormalities.